Overview
Yetunde Akinola-John practices practicing medicine in Ibadan, Nigeria.
Her clinical expertise encompasses Cervical Cancer, Anal Cancer, and Human Papillomavirus Infection.
She is actively involved in clinical research, co-authoring 32 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yetunde O. Akinola-John
Is Yetunde O. Akinola-John a top-rated expert for Cervical Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yetunde O. Akinola-John is classified as an Experienced expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yetunde O. Akinola-John participate in research or clinical trials?
Yes. Yetunde O. Akinola-John has published 32 articles and abstracts on conditions like Cervical Cancer. You can view a list of Yetunde O. Akinola-John's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerMs. Akinola-John isExperienced. Learn about Anal Cancer.
- Cervical CancerMs. Akinola-John isExperienced. Learn about Cervical Cancer.
- Human Papillomavirus InfectionMs. Akinola-John isExperienced. Learn about Human Papillomavirus Infection.